MedicarePartD.guide

A non-government resource built from CMS public data

Kisqali on Wellcare Value Script (S4802-132)

ribociclib

Covered, with prior authorization required.

Tier 5 (specialty tier). Quantity limit of 21 per 28 days.

$1,813.45
Patient pays / month, after deductible
$2,274.70
Patient pays / month, before the $615.00 deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

KISQALI 200 mg Tablet, Film Coated at a preferred retail pharmacy, from the plan's negotiated price of $7,253.80 for a month. Other covered strengths are listed below.

Prior authRequired on all 3 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 3 covered strengths and forms
FormTierPatient pays / monthLimits
KISQALI 200 mg Tablet, Film Coated5$1,813.45PA · 21 per 28 days
KISQALI 200 mg Tablet, Film Coated5$3,684.33PA · 42 per 28 days
KISQALI 200 mg Tablet, Film Coated5$4,608.92PA · 63 per 28 days

Other CDK4/6 inhibitors on this plan

Verify with the plan before prescribing or filling. Member services: (888)550-5252. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s4802-132